Literature DB >> 17696911

Cardiac and aortic structural alterations due to surgically-induced menopause associated with renovascular hypertension in rats.

Leonardo de Souza Mendonça1, Caroline Fernandes-Santos, Carlos Alberto Mandarim-de-Lacerda.   

Abstract

Menopause and hypertension independently alter cardiovascular remodelling, but little is known about their effect on left ventricular and aortic wall remodelling. Eight-weeks-old Wistar rats were divided into four groups of six animals each: Sham group, OVX group (ovariectomized rats), 2K1C (two-kidneys, one-clip rats) and OVX + 2K1C group and kept until 19 weeks. Blood pressure (BP) increased 12% in OVX group, 35% in 2K1C and OVX + 2K1C groups compared with sham group. Vaginal cytology showed Sham and 2K1C rats cycling normally, whereas OVX and OVX + 2K1C rats were persistently in dioestrus or proestrus. At euthanasia, left ventricle (LV) and thoracic aorta were removed and analysed (immunohistochemistry and stereology). LV mass/tibia length ratio and cross-sectional area of cardiomyocytes increased in all groups except Sham. The intramyocardial vascularization reduced 30% in comparison with Sham group, with no difference among OVX, 2K1C and OVX + 2K1C groups. The cardiac interstitium increased more than 45% in both 2K1C and OVX + 2K1C groups compared with Sham, but there was no significant difference between Sham and OVX groups. Nuclei number of LV cardiomyocyte diminished in OVX group, followed by 2K1C group and OVX + 2K1C group, with no difference between the 2K1C and the OVX + 2K1C groups. There was positive immunostaining for angiotensin II AT1 receptor in smooth muscle cell layer of aortic tunica media in all groups. These results show that both ovariectomy and renovascular hypertension enhance BP as a single stimulus and therefore produce adverse cardiac remodelling. However, renovascular hypertension exerts a far greater influence than surgically-induced menopause in this parameter.

Entities:  

Mesh:

Year:  2007        PMID: 17696911      PMCID: PMC2517315          DOI: 10.1111/j.1365-2613.2007.00546.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  35 in total

Review 1.  Stereological tools in biomedical research.

Authors:  Carlos A Mandarim-de-Lacerda
Journal:  An Acad Bras Cienc       Date:  2003-11-04       Impact factor: 1.753

Review 2.  Is menopause an independent cardiovascular risk factor? Evidence from population-based studies.

Authors:  Edoardo Casiglia; Valérie Tikhonoff; Paolo Mormino; Antonio Piccoli; Achille C Pessina
Journal:  J Hypertens Suppl       Date:  2002-05

Review 3.  Systemic hypertension in postmenopausal women: a clinical approach.

Authors:  Enrique Z Fisman; Alexander Tenenbaum; Amos Pines
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

Review 4.  Female sex hormones, salt, and blood pressure regulation.

Authors:  Antoinette Pechère-Bertschi; Michel Burnier
Journal:  Am J Hypertens       Date:  2004-10       Impact factor: 2.689

Review 5.  Basic research into the mechanisms responsible for postmenopausal hypertension.

Authors:  Jane F Reckelhoff
Journal:  Int J Clin Pract Suppl       Date:  2004-03

6.  Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension.

Authors:  Danesh Javeshghani; Rhian M Touyz; M Ram Sairam; Agostino Virdis; Mario Fritsch Neves; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2003-07-28       Impact factor: 10.190

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  The effect of enalapril on the cardiac remodelling in ovariectomized spontaneously hypertensive rats.

Authors:  Wellington V Santos; Leila M M Pereira; Carlos A Mandarim-de-Lacerda
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

9.  Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the periphery.

Authors:  Eric Lazartigues; Andrew J Lawrence; Fred S Lamb; Robin L Davisson
Journal:  Circ Res       Date:  2004-07-29       Impact factor: 17.367

10.  Menopause induced by oophorectomy reveals a role of ovarian estrogen on the maintenance of pressure homeostasis.

Authors:  Giuseppe Mercuro; Sandra Zoncu; Francesca Saiu; Monica Mascia; Gian Benedetto Melis; Giuseppe M C Rosano
Journal:  Maturitas       Date:  2004-02-20       Impact factor: 4.342

View more
  4 in total

1.  Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats.

Authors:  João Paulo Gabriel Camporez; Eliana Hiromi Akamine; Ana Paula Davel; Celso Rodrigues Franci; Luciana Venturini Rossoni; Carla Roberta de Oliveira Carvalho
Journal:  J Physiol       Date:  2011-03-14       Impact factor: 5.182

2.  White spotting variant mouse as an experimental model for ovarian aging and menopausal biology.

Authors:  Elizabeth R Smith; Toni Yeasky; Jain Qin Wei; Roberto A Miki; Kathy Q Cai; Jennifer L Smedberg; Wan-Lin Yang; Xiang-Xi Xu
Journal:  Menopause       Date:  2012-05       Impact factor: 2.953

3.  Favorable cardiac and aortic remodeling in olmesartan-treated spontaneously hypertensive rats.

Authors:  Caroline Fernandes-Santos; Leonardo de Souza Mendonça; Carlos Alberto Mandarim-de-Lacerda
Journal:  Heart Vessels       Date:  2009-05-24       Impact factor: 2.037

4.  Vimentin and laminin are altered on cheek pouch microvessels of streptozotocin-induced diabetic hamsters.

Authors:  Jemima Fuentes R Silva; Fatima Z G A Cyrino; Marisa M D Breitenbach; Eliete Bouskela; Jorge José Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.